Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

nanoparticle formulation CPI-300

A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:nanoscale coordination polymer-based formulation CPI-300
NCP platform-based CPI-300
Code name:CPI 300
CPI-300
CPI300
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search